Overview

Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337

Status:
Completed
Trial end date:
2018-11-13
Target enrollment:
Participant gender:
Summary
Compare the pharmacokinetic characteristics and safety between CKD-391 tablet and D337, D337 combination
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical